BioCentury
ARTICLE | Clinical News

LAS41008: Phase III data

October 10, 2016 7:00 AM UTC

The double-blind, international Phase III BRIDGE trial in about 839 patients with moderate to severe chronic plaque psoriasis showed that LAS41008 met the co-primary endpoints of improving PASI 75 res...